**Question:** All of the following are good prognostic factors for acute lymphoblastic leukemia, except:

A. Age
B. Complete remission
C. Minimal residual disease (MRD)
D. White blood cell count (WBC)

**Core Concept:** Good prognostic factors in acute lymphoblastic leukemia (ALL) are variables that indicate a favorable clinical outcome. These factors help in predicting the response to treatment and overall survival in patients with ALL.

**Why the Correct Answer is Right:** Age is a crucial factor in pediatric ALL patients as they have a higher likelihood of achieving remission and better survival rates compared to adult ALL patients. However, age is not a favorable prognostic factor in adults with ALL.

**Why Each Wrong Option is Incorrect:**

A. Age (Option B): In pediatric ALL patients, age is a good prognostic factor because they have a higher likelihood of achieving remission and better survival rates compared to adult ALL patients. In this context, age is considered unfavorable for adults, making it incorrect.

B. Complete remission (Option B): Complete remission (CR) indicates successful treatment and a favorable prognosis in ALL patients. However, considering the options provided, Option B is correct for ALL patients but is not specifically mentioned as a wrong factor in this question.

C. Minimal residual disease (MRD) (Option C): MRD is a positive prognostic factor in ALL patients as it indicates that the cancer cells have been effectively eliminated after treatment.

D. White blood cell count (WBC) (Option D): A high WBC count is generally considered a poor prognostic factor in ALL patients, as it indicates a more aggressive disease and higher risk of relapse.

**Clinical Pearl:** Prognostic factors are essential in clinical decision-making for ALL treatment plans. Evaluating these factors allows healthcare professionals to tailor therapy to the patient's specific condition, improving the chances of successful treatment and better patient outcomes.

**Correct Answer:** Option D (White blood cell count) is considered a poor prognostic factor in ALL patients, indicating a more aggressive disease and higher risk of relapse. While it is essential to evaluate prognostic factors in ALL treatment planning, considering only the WBC count as a poor prognostic factor is not comprehensive. Evaluating multiple factors helps in creating a more personalized treatment plan for ALL patients.